News
Sports
Life
Opinion
Business
Advertise
Obituaries
eNewspaper
Legals
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
NewsOK Local Stocks
NewsOK Local Stocks
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Boston Scientific
(NY:
BSX
)
79.17
-0.41 (-0.52%)
Official Closing Price
Updated: 7:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Boston Scientific
< Previous
1
2
3
4
5
6
7
8
9
...
13
14
Next >
Stryker Stock Sees Relative Strength Rating Jump To 84
February 01, 2024
The Relative Strength (RS) Rating for Stryker stock jumped into a new percentile Thursday, with a rise from 76 to 84.
Via
Investor's Business Daily
AT&T To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Thursday
February 01, 2024
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
Via
Benzinga
Key Takeaways From Boston Scientific Analyst Ratings
February 01, 2024
Via
Benzinga
Biotech And Medtech Portfolio Notes On A Fed Day
January 31, 2024
The Fed held rates keeping their future options flexible with no expectations for future cuts. The market did not like it and sold off with the Russell 2000 down 2.45% and the NASDAQ down 2.23%
Via
Talk Markets
Topics
Economy
Exposures
Interest Rates
Nasdaq, S&P 500 Slip Ahead Of Fed Meeting, Regional Banks Sink After NYCB Disappoints: What's Driving Markets Wednesday?
January 31, 2024
Nasdaq down 1.4%, S&P 500 down 0.9%, Dow up: Volatile day on Wall Street as tech stocks react to disappointing earnings ahead of Fed meeting.
Via
Benzinga
Topics
Economy
Stocks
Exposures
Interest Rates
US Equities
Why Medical Devices Giant Boston Scientific Shares Are Rising Today
January 31, 2024
Boston Scientific shares surge in premarket trading following strong Q4 results, beating revenue estimates, amid positive outlook for 2024.
Via
Benzinga
Boston Scientific Surges On Its 'Impressive' First-Quarter Guidance
January 31, 2024
The company expects sales to grow 7% to 9% organically, above expectations.
Via
Investor's Business Daily
Stryker, Boston Scientific Score Earnings Beats, Extend Breakouts
January 31, 2024
Shares of Stryker, Boston Scientific jumped early Wednesday after healthy earnings beats and price target hikes from analysts.
Via
Investor's Business Daily
Topics
Earnings
Exposures
Financial
Nasdaq Futures Plummet As Alphabet, AMD Disappointments Sour Sentiment; Spotlight Shifts To Fed Statement, Powell's Presser
January 31, 2024
The record run of the market faces risk as the big tech earnings season got off to a negative start, casting cloud on profit outlook.
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
Preview: Boston Scientific's Earnings
January 30, 2024
Via
Benzinga
Looking Into Boston Scientific's Recent Short Interest
January 23, 2024
Via
Benzinga
Demystifying Boston Scientific: Insights From 10 Analyst Reviews
January 16, 2024
Via
Benzinga
Earnings Scheduled For January 31, 2024
January 31, 2024
Companies Reporting Before The Bell • Novartis (NYSE:NVS) is likely to report quarterly earnings at $1.68 per share on revenue of $11.56 billion.
Via
Benzinga
Why Axonics Stock Soared Today
January 08, 2024
The medical device maker agreed to be acquired by Boston Scientific.
Via
The Motley Fool
Boston Scientific Corporation Should Continue Uptrend & Remain Supported
January 30, 2024
Boston Scientific Corporation develops, manufactures & markets medical devices for use in various interventional medical specialties worldwide. It operates through MedSurg & Cardiovascular segments.
Via
Talk Markets
Tech Titans Microsoft, Apple Lead 'Magnificent Seven' Earnings Wave This Week: Can Mega-Caps Ignite Market Optimism?
January 29, 2024
An analyst sees the Satya Nadella-led company's earnings to be the key barometer for AI spending.
Via
Benzinga
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Health Care Company Boston Scientific Announces Acquisition of Axonics
January 08, 2024
Via
Benzinga
Arterial Device-Focused Inari Medical Likely Acquisition Target, Shares Are Attractively Valued: Analyst
January 23, 2024
Inari Medical with strong position in venous thrombectomy. Buy-rated by Needham with a $72 target. Undervalued shares with an 88% gross margin and anticipated double-digit revenue growth.
Via
Benzinga
Chart Of The Day: Boston Scientific - Revenue Growth Potential
January 18, 2024
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide.
Via
Talk Markets
Palo Alto Networks, Nvidia, And 2 Other Stocks Insiders Are Selling
January 17, 2024
The Nasdaq 100 closed slightly lower on Tuesday. Investors, meanwhile, focused on some notable insider trades.
Via
Benzinga
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Ambrx Biopharma, Inc. (Nasdaq – AMAM), Gracell Biotechnologies Inc. (Nasdaq – GRCL), Axonics, Inc. (Nasdaq - AXNX), Harpoon Therapeutics, Inc. (Nasdaq - HARP)
January 16, 2024
From
Brodsky & Smith LLC
Via
GlobeNewswire
7 Healthcare Stocks Taking Medicine to the Next Level
January 14, 2024
With advances in technology potentially able to improve the human condition, these are the compelling healthcare stocks to consider.
Via
InvestorPlace
Stock Market Rally Rebounds; Nvidia, Tesla, JPMorgan, Bitcoin ETFs In Focus: Weekly Review
January 12, 2024
The major indexes and leading stocks rebounded. Bitcoin ETFs fell in their debut.
Via
Investor's Business Daily
Topics
ETFs
5 A-Rated Stocks to Buy ASAP in 2024
January 10, 2024
2024 is ushering in a new era for investors, and these top-notch, A-rated stocks to buy are likely to be market winners. Here's why.
Via
InvestorPlace
10 Top Stocks With a Strong Buy Rating Right Now
January 09, 2024
Wall Street is highly bullish on these strong buy stocks, even as financial markets face an uncertain year. Here are the names to watch.
Via
InvestorPlace
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Ambrx Biopharma, Inc. (Nasdaq – AMAM), Gracell Biotechnologies Inc. (Nasdaq – GRCL), Axonics, Inc. (Nasdaq - AXNX), Harpoon Therapeutics, Inc. (Nasdaq - HARP)
January 08, 2024
From
Brodsky & Smith LLC
Via
GlobeNewswire
10 Health Care Stocks With Whale Alerts In Today's Session
January 08, 2024
Via
Benzinga
Why Is Axonics (AXNX) Stock Up 20% Today?
January 08, 2024
Axonics stock is rising higher on Monday as investors react to a $71 per share cash offer for AXNX stock from Boston Scientific.
Via
InvestorPlace
Why Is Bladder Disorder Focused Axonics Stock Trading Higher Today?
January 08, 2024
Boston Scientific Corporation (NYSE: BSX) has agreed to acquire Axonics Inc (NASDAQ: AXNX) for $7
Via
Benzinga
J&J, Merck, Boston Scientific Debut Trio Of Splashy Takeovers Topping $3 Billion In Value
January 08, 2024
The year's biggest medical conference kicked off with a melee of buyout news.
Via
Investor's Business Daily
< Previous
1
2
3
4
5
6
7
8
9
...
13
14
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.